Author Question: The International Classification of Functioning, Disability and Health: a. Has a schema for scoring ... (Read 85 times)

brutforce

  • Hero Member
  • *****
  • Posts: 540
The International Classification of Functioning, Disability and Health:
 a. Has a schema for scoring health outcomes
  b. Provides a systematic scoring system across the dimensions
  c. Has impacted assessment and documentation in rehabilitation professions
  d. All of these

Question 2

Enablement theory was developed to describe the fact that:
 a. Assessment not directly done on the problem that is the target of the intervention requires enabling links
  b. Assessment enables the development of a treatment plan
  c. Assessment should be ongoing
  d. Assessment is not necessary is most settings, but is enabled at certain points in the course of intervention



amynguyen1221

  • Sr. Member
  • ****
  • Posts: 355
Answer to Question 1

d

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library